DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ArQule, Inc. (ARQL)
« Back to company indexARQL Chatter Timeline
Stock Ticker for ARQL
Most Active Tweeters for ARQL
| User | Tweets |
|---|---|
| @JE70019176 | 1 |
| @gcbioinv | 1 |
| @HealthcareBeat | 1 |
Recent Tweets for ARQL
 |
@gcbioinv After $ARQL was purchased by $MRK during ASH 2019 many folks on here made generous contributions to various related… https://t.co/smz8SFlapl March 30th 2020, 3:03pm |
 |
@JE70019176 RT @RudyHavenstein: I told my Premium Twitter subscribers yesterday to put all their money into ArQule, Inc. shares. $ARQL March 29th 2020, 8:03pm |
 |
@HealthcareBeat Man Group Acquires Shares of 1,108,960 ArQule $ARQL https://t.co/OwFSi4xKX9 March 28th 2020, 8:03pm |
 |
@dispatchtribune Analyzing Kaya $KAYS & ArQule $ARQL https://t.co/OVa2uh2K0a March 26th 2020, 6:03am |
|
@HealthcareBeat Glazer Capital Makes New Investment in ArQule $ARQL https://t.co/v2ZcmsKB7t March 23rd 2020, 10:03pm |
 |
@thomasmcdanie20 $arql on your list twice. Time to update https://t.co/LCOKeC45Of March 23rd 2020, 8:03am |
 |
@ThisLincolnian Head-To-Head Review: Kaya $KAYS and ArQule $ARQL https://t.co/hXHjQYcRuZ March 22nd 2020, 1:03am |
 |
@TickerReport Head-To-Head Review: Kaya $KAYS and ArQule $ARQL https://t.co/8SsPE5hdrh March 22nd 2020, 1:03am |
|
@HealthcareBeat ArQule Receives $17.50 Consensus Target Price from Brokerages $ARQL https://t.co/TlOKE9sc4g March 21st 2020, 5:03pm |
 |
@stocknewstimes ArQule, Inc. $ARQL Receives $17.50 Consensus Target Price from Brokerages https://t.co/IJnAZcUaHE March 21st 2020, 12:03pm |
 |
@WeekHerald Analysts Set ArQule, Inc. $ARQL PT at $17.50 https://t.co/nYAiw9nXWH March 21st 2020, 12:03pm |
 |
@EnterpriseLeade ArQule, Inc. $ARQL Given Consensus Recommendation of “Hold” by Brokerages https://t.co/ZcwFqGPPQ4 March 18th 2020, 3:03am |
 |
@AmericanBanking ArQule, Inc. $ARQL Given Consensus Recommendation of “Hold” by Brokerages https://t.co/dkH9rYxANZ #stocks March 18th 2020, 3:03am |
 |
@sharkbiotech RT @adar170: So anyone upset @ $arql Mgmt about “only” getting 20 from Merck ? March 18th 2020, 12:03am |
 |
@adar170 So anyone upset @ $arql Mgmt about “only” getting 20 from Merck ? March 12th 2020, 3:03pm |
 |
@GantosJ Looks like $APTO retail traders were expecting to get a PR (partial response) news!!! But, from $ARQL study it take… https://t.co/pahMW98mqu March 11th 2020, 11:03am |
 |
@mtheory11bio @funstocks1 I don’t believe $ARQL had any other bidders March 10th 2020, 6:03pm |
 |
@Gambiste1 RT @KevinDuska: @VenetoLibero198 Oh that's my monopoly money but FWIW I've had massive successes. Bought $ARQL under $3 - sold 75% when it… March 8th 2020, 10:03pm |
 |
@KevinDuska @VenetoLibero198 Oh that's my monopoly money but FWIW I've had massive successes. Bought $ARQL under $3 - sold 75%… https://t.co/cL0u5C3AnG March 8th 2020, 8:03pm |
 |
@BertrandBio @Bermudashorts2 @RedxPharma after $MRK buying $ARQL, you can just be frustrated if not gutted, that the former inve… https://t.co/mhM5g1MZom March 2nd 2020, 3:03am |
|
@HealthcareBeat ArQule Shares Bought by Swiss National Bank $ARQL https://t.co/s080xCk7it March 1st 2020, 5:03am |
|
@HealthcareBeat Sowell Financial Services Purchases 750 Shares of ArQule $ARQL https://t.co/zMrmWEZXu0 March 1st 2020, 3:03am |
 |
@newsfilterio ArQule Shares Bought by Swiss National Bank $ARQL https://t.co/yVbgX4TvxA February 29th 2020, 2:02am |
|
@newsfilterio Sowell Financial Services Purchases 750 Shares of ArQule $ARQL https://t.co/w8jA0RA5PC February 29th 2020, 1:02am |
|
@HealthcareBeat 18,000 Shares in ArQule Acquired by Meitav Dash Investments $ARQL https://t.co/N8DIFF0fJr February 28th 2020, 3:02am |
 |
@WatchlistN Analysts Set ArQule, Inc. $ARQL Price Target at $17.50 https://t.co/qPljtTtbic February 25th 2020, 4:02pm |
|
@dakotafinancial ArQule, Inc. $ARQL Receives $17.50 Average PT from Brokerages https://t.co/p2l2b5EOyt February 25th 2020, 4:02pm |
 |
@TranscriptDaily ArQule, Inc. $ARQL Receives $17.50 Average PT from Brokerages https://t.co/VwbZIltH0n February 25th 2020, 4:02pm |
|
@GantosJ Today is the day I'm saying last goodbye to $ARQL along with all options holders who kept their calls post $MRK tak… https://t.co/arbk76qnpM February 24th 2020, 9:02am |
|
@TickerReport ArQule, Inc. $ARQL Given Average Recommendation of “Hold” by Analysts https://t.co/6dMa5wzpnL February 22nd 2020, 1:02am |
|
@AmericanBanking ArQule, Inc. $ARQL Given Average Recommendation of “Hold” by Analysts https://t.co/UzUAGRl9Ig #stocks February 22nd 2020, 1:02am |
 |
@SEL421 @PersimmonTI Think it gets taken out for superior valuation over $ARQL? February 18th 2020, 1:02pm |
|
@HealthcareBeat Form SC 13G (statement of acquisition of beneficial ownership by individuals) filed with the SEC $ARQL https://t.co/7F1dxmWyU8 February 17th 2020, 10:02pm |
|
@dakotafinancial Analyzing Prestige Consumer Healthcare $PBH & ArQule $ARQL https://t.co/Yr17f23Q86 February 17th 2020, 4:02am |
|
@Maverick_IT1 RT @semodough: 2years ago most analysts were just coming around to $ARQL story - last month many inniations of $APTO - will history repeat… February 16th 2020, 6:02pm |
 |
@semodough 2years ago most analysts were just coming around to $ARQL story - last month many inniations of $APTO - will histor… https://t.co/FIALxXCB3b February 16th 2020, 1:02pm |
 |
@Lin_ling_88 Typo: should read $ARQL February 16th 2020, 12:02am |
|
@HealthcareBeat Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $ARQL https://t.co/qBvoFA2shf February 15th 2020, 10:02pm |
 |
@dailypoliticaln Prestige Consumer Healthcare $PBH versus ArQule $ARQL Critical Analysis https://t.co/7Mbw8nTj4U February 15th 2020, 3:02am |
|
@newsfilterio Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $ARQL https://t.co/Mq2MvP7YNG February 15th 2020, 12:02am |
 |
@fintel_io Biotechnology Value Fund L P has filed an amended 13G/A, reporting 4.0% ownership in $ARQL - https://t.co/xnPFfrCxc9 February 14th 2020, 6:02pm |
|
@fintel_io Consonance Capital Management LP has filed a new 13G, reporting 5.56% ownership in $ARQL - https://t.co/xnPFfrCxc9 February 14th 2020, 12:02pm |
 |
@Stock_News_Now $ARQL: New SEC Filing for ARQL: Form SC 13G (No. 0001085146-20-000755): https://t.co/xW7tsJdFqG February 14th 2020, 12:02pm |
 |
@RTFilingsStocks Consonance Capital Management LP files 13G disclosing 5.56% stake in $ARQL https://t.co/wsLt98BQlQ February 14th 2020, 12:02pm |
 |
@ZolmaxNews Comparing ArQule $ARQL & Prestige Consumer Healthcare $PBH https://t.co/fo5aHfMuGs February 13th 2020, 2:02am |
|
@fintel_io Integrated Core Strategies (us) Llc has filed an amended 13G/A, reporting 1.1% ownership in $ARQL - https://t.co/xnPFfrCxc9 February 12th 2020, 6:02pm |
|
@Stock_News_Now $ARQL: New SEC Filing for ARQL: Form SC 13G/A (No. 0001319244-20-000049): https://t.co/y3YLNJkWiZ February 12th 2020, 5:02pm |
|
@fintel_io Nantahala Capital Management, LLC has closed their entire position in $ARQL - https://t.co/xnPFfrCxc9 February 10th 2020, 2:02pm |
|
@Stock_News_Now $ARQL: New SEC Filing for ARQL: Form SC 13G/A (No. 0001104659-20-013291): https://t.co/y5DjOvMOhp February 10th 2020, 1:02pm |
|
@TickerReport Comparing ArQule $ARQL and Prestige Consumer Healthcare $PBH https://t.co/GNBKrp8CQJ February 10th 2020, 4:02am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.